Search results for "time factor"

showing 10 items of 3219 documents

The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transpl…

2020

BACKGROUND There is a lack of data on the use of direct-acting antivirals (DAA) on the risk of death and tumoral recurrence in patients with hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) listed for liver transplantation (LT). We aimed to assess the impact of antiviral treatment on mortality and HCC recurrence patients with HCC-HCV. METHODS This was a retrospective multicenter study of patients with HCC-HCV listed for LT from 2005 to 2015. Patients were divided according to the antiviral treatment received after HCC diagnosis: DAA, interferon (IFN), or no antiviral. Intention-to-treat overall survival and HCC recurrence incidence were compared by the Kaplan-Meier method. Multiva…

Malemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsWaiting Listsmedicine.medical_treatment030230 surgeryLiver transplantationGastroenterologyAntiviral AgentsRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCarcinomamedicineHumansRisk factorRetrospective StudiesTransplantationbusiness.industryIncidence (epidemiology)Hazard ratioLiver NeoplasmsRetrospective cohort studyMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesLiver TransplantationTreatment OutcomeHepatocellular carcinoma030211 gastroenterology & hepatologyFemaleNeoplasm Recurrence LocalbusinessTransplantation
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation

2009

Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long-term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure. Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV-AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsThromboembolism.left atrial appendage occlusionmedicine.medical_treatmentEmbolismSettore MED/11 - Malattie dell'Apparato CardiovascolareTransesophagealLeft atrial appendage occlusionPericardial effusionRisk AssessmentLeft atrialInternal medicineAtrial FibrillationmedicineHumansRadiology Nuclear Medicine and imagingAtrial Appendageatrial fibrillation; left atrial appendage occlusion; thromboembolism; Aged; Atrial Fibrillation; Contraindications; Echocardiography Transesophageal; Embolism; Equipment Design; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Anticoagulants; Atrial Appendage; Cardiac Catheterization; Chronic DiseaseStrokeAgedbusiness.industryContraindicationsAnticoagulantsAtrial fibrillationGeneral MedicineEquipment DesignthromboembolismMiddle Agedmedicine.diseaseSurgeryStrokeTreatment OutcomePericardiocentesisEchocardiographyChronic DiseaseCardiologyPatent foramen ovaleFeasibility StudiesFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealPlatelet Aggregation Inhibitors
researchProduct

Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation

2013

ObjectivesThis study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]).BackgroundRisk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need.MethodsCA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transforma…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsAortic Valve InsufficiencyMyocardial InfarctionKaplan-Meier EstimateRisk AssessmentCA125Interquartile rangeRisk FactorsInternal medicineMedicineHumansMyocardial infarctionLongitudinal StudiesRegistriesStroketranscatheter aortic valve implantationTumor markerAgedProportional Hazards ModelsAged 80 and overHeart FailureHeart Valve Prosthesis ImplantationProportional hazards modelbusiness.industryMembrane ProteinsAortic Valve Stenosismedicine.diseasejoint modelingHospitalizationStrokeLogistic ModelsTreatment OutcomeCardiovascular DiseasesHeart failureCA-125 AntigenMultivariate AnalysisCardiologybiomarkerBiomarker (medicine)FemaleprognosisbusinessCardiology and Cardiovascular MedicineMaceBiomarkersJACC: Cardiovascular Interventions
researchProduct

Long-term beneficial effects of PTCA on segmental early relaxation in disease of the left anterior descending coronary artery.

1988

The relationship between regional left ventricular (LV) motion and global pressure relaxation of the left ventricle remains unclear. To clarify the recent concept of segmental early relaxation in coro nary artery disease, the authors in vestigated two groups of patients. In group I, all 12 patients (mean age 47±7 years) exhibited evidence of a normal heart after an extensive in vestigation. In group II, 25 patients (55±7 years) presented an isolated stenosis of the left anterior descend ing coronary artery, and they under went a hemodynamic investigation before and after (six to nine months) a durable successful percutaneous transluminal coronary angioplasty (PTCA). After all conventional …

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHeart VentriclesHemodynamicsCoronary Disease030204 cardiovascular system & hematologyAnterior Descending Coronary Artery03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineBeneficial effectsRelaxation (psychology)business.industryHemodynamicsMiddle Agedmedicine.diseaseMyocardial ContractionSurgeryStenosismedicine.anatomical_structureVentricleCoronary vesselCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonArteryFollow-Up StudiesAngiology
researchProduct

Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.

2020

This study was designed to assess hemodynamic changes in response to transcatheter tricuspid valve edge-to-edge repair (TTVR) and to identify hemodynamic predictors associated with mortality.Severe tricuspid regurgitation (TR) is associated with high mortality. TTVR effectively alleviates heart failure symptoms, but comprehensive hemodynamic characterization of patients undergoing TTVR is currently lacking.This international, multicenter study included 236 patients undergoing TTVR. Data from clinical assessment, echocardiography, intraprocedural right heart catheterization, and noninvasive cardiac output measurement were analyzed. Hemodynamic predictors for mortality were identified using l…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHemodynamicsRegurgitation (circulation)030204 cardiovascular system & hematologyNew york heart association03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineTRICUSPID VALVE REPAIRAgedHeart FailureHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryProportional hazards modelHemodynamicsRecovery of Functionmedicine.diseaseTricuspid Valve Insufficiencymedicine.anatomical_structureTreatment OutcomeMulticenter studyHeart failureCardiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessJACC. Cardiovascular interventions
researchProduct

Chest pain due to late huge coronary pseudoaneurysm following stent implantation

2011

A 50-year-old man was referred to our hospital because of persistent atypical chest pain. His past medical history was remarkable for a non ST elevation myocardial infarction, treated five months previously with PCI on the right coronary artery. Two months later, for chest pain, he underwent coronary angiography that showed a right coronary artery with slight ectasia near the stent. Five months later for the persistence of atypical chest pain he came to our clinic. Chest CT showed a 31.5 mm hematoma of the right coronary artery. Coronary angiography revealed a giant aneurysm, proximal to the stent. In the light of rapid growth of aneurysm, the risk of rupture and symptoms, we decided to tre…

Malemedicine.medical_specialtyChest PainTime Factorsmedicine.medical_treatmentChest painCoronary AngiographyHematomaAneurysmEctasiamedicine.arteryInternal MedicinemedicineStentHumanscardiovascular diseasesMyocardial infarctionCoronary Vesselbusiness.industryStentGeneral MedicineMiddle Agedmedicine.diseaseCoronary Vesselssurgical procedures operativeRight coronary arteryConventional PCIStentsRadiologymedicine.symptombusinessAneurysm FalseHuman
researchProduct

Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.

2018

Aim: Assessing the incidence of immediate postoperative complications and 90-day mortality in high-risk patients who have undergone radical cystectomy; evaluating the correlation between preoperative conditions and surgery outcomes. Materials and methods: This is a monocentric retrospective observational study in which data of 65 patients have been analyzed. High-risk criteria: (a) Age ≥75 years, (b) obesity, (c) age-adjusted Charlson Comorbidity Index ≥8, (d) anemic status, and (e) pT ≥3. More than 50% of patients had two or more “high-risk” indicators. Postoperative complications were assessed through Clavien–Dindo classification. Results: Average age of patients was 70.4 years, average a…

Malemedicine.medical_specialtyClavien-Dindo ClassificationTime Factorsmedicine.medical_treatment030232 urology & nephrologyCystectomyRisk AssessmentSettore MED/24 - UrologiaCystectomy03 medical and health sciences0302 clinical medicinePostoperative ComplicationsmedicineHumansRisk factorAgedRetrospective Studiesbusiness.industryMortality rateIncidence (epidemiology)Retrospective cohort studyGeneral MedicineOdds ratioMiddle AgedSurgeryUrinary Bladder Neoplasms030220 oncology & carcinogenesisRadical cystectomy bladder cancer Clavien–Dindo classification complications and mortalityFemalebusinessBody mass indexUrologia
researchProduct

Chronic psychosocial stress and antidepressant treatment in tree shrews: time-dependent behavioral and endocrine effects.

1999

Abstract Social defeat has been shown to cause a number of behavioral, physiological, and central nervous changes in male tree shrews. The present study was designed to assess: (i) a potential time lag in the occurrence of behavioral alterations (locomotor activity, self-grooming, marking behavior, food and water intake, and avoidance behavior) after stress and long-term antidepressant treatment; and (ii) to investigate potential interactions between behavioral and endocrine variables (urinary cortisol and norepinephrine). Male tree shrews were submitted to chronic psychosocial stress for 39 days. In this paradigm, the stress-induced behavioral and endocrine alterations in subordinate anima…

Malemedicine.medical_specialtyClomipramineHypothalamo-Hypophyseal SystemSympathetic Nervous SystemTime FactorsHydrocortisonemedicine.drug_classCognitive NeuroscienceDrinkingTricyclic antidepressantPituitary-Adrenal SystemSocial defeatBehavioral NeuroscienceEatingNorepinephrineInternal medicineEndocrine GlandsmedicineAnimalsHydrocortisoneBehavior AnimalBehavior changeTupaiidaeGroomingAntidepressive AgentsNeuropsychology and Physiological PsychologyEndocrinologyPsychotropic drugChronic DiseaseCatecholamineAntidepressantPsychologyStress Psychologicalmedicine.drugNeuroscience and biobehavioral reviews
researchProduct

Changes in the structure of the agonistic behavior of mice produced by D-amphetamine.

1997

The effects of three acute doses of D-amphetamine (0.25, 1.5 and 3 mg/kg) were studied in a model of isolation-induced aggression in male mice. An ethopharmacological analysis of the encounters was carried out, which studied the frequency, total and mean duration of different behavioral categories, including the temporal distribution of attacks and the duration of inter-attack intervals. The results show a reduction in the total and mean duration of the Attack category and an increase in motor activity manifested by longer durations, both total and mean, of Non Social Exploration and shorter Immobility. The temporal analysis of Attack revealed an increase in the number of very short (< 15 s…

Malemedicine.medical_specialtyDextroamphetamineTime FactorsClinical BiochemistryAudiologyMotor ActivityToxicologyBiochemistryDevelopmental psychologyBehavioral NeuroscienceMicemedicineAgonistic behaviourAnimalsMotor activityAmphetamineSocial BehaviorSensory cueBiological PsychiatryPharmacologyAggressionDextroamphetamineSocial relationSocial IsolationDuration (music)Exploratory BehaviorCentral Nervous System Stimulantsmedicine.symptomStereotyped BehaviorPsychologyAgonistic Behaviormedicine.drugPharmacology, biochemistry, and behavior
researchProduct